Notify me when Casdin Capital, LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 38 | $1,609,916,188 | +$188,846,003 | -$111,324,800 | +$77,521,203 | WGS, RVMD, BLFS, LAB, RLAY | 13F-HR | 17 Feb 2026, 16:05 |
| Q3 2025 | 32 | $1,199,325,239 | +$84,092,199 | -$210,922,893 | -$126,830,694 | WGS, BLFS, RVMD, LAB, RNA | 13F-HR | 14 Nov 2025, 16:09 |
| Q2 2025 | 33 | $1,098,157,889 | +$37,908,864 | -$200,511,754 | -$162,602,890 | WGS, BLFS, RVMD, LAB, ILMN | 13F-HR | 14 Aug 2025, 16:27 |
| Q1 2025 | 44 | $1,223,806,401 | +$57,618,153 | -$58,970,974 | -$1,352,821 | WGS, BLFS, RVMD, LAB, RNA | 13F-HR | 15 May 2025, 16:07 |
| Q4 2024 | 38 | $1,495,471,143 | +$65,804,872 | -$48,920,249 | +$16,884,623 | WGS, BLFS, RVMD, SRPT, LAB | 13F-HR | 14 Feb 2025, 16:04 |
| Q3 2024 | 35 | $1,499,957,209 | +$100,529,921 | -$49,871,705 | +$50,658,216 | BLFS, RVMD, WGS, LAB, SRPT | 13F-HR | 14 Nov 2024, 16:11 |
| Q2 2024 | 38 | $1,309,655,420 | +$66,196,212 | -$121,349,198 | -$55,152,986 | BLFS, RVMD, SRPT, LAB, WGS | Restatement | 18 Oct 2024, 17:25 |
| Q1 2024 | 36 | $1,343,816,497 | +$285,648,560 | -$68,584,401 | +$217,064,159 | RVMD, LAB, BLFS, SRPT, RLAY | 13F-HR | 15 May 2024, 16:05 |
| Q4 2023 | 36 | $1,014,239,385 | +$199,911,865 | -$140,021,851 | +$59,890,014 | RVMD, BLFS, SRPT, RLAY, GPCR | 13F-HR | 14 Feb 2024, 16:06 |
| Q3 2023 | 38 | $896,552,441 | +$65,228,169 | -$113,181,480 | -$47,953,311 | SRPT, BLFS, EQRX, GPCR, RLAY | 13F-HR | 14 Nov 2023, 16:12 |
| Q2 2023 | 41 | $1,144,294,659 | +$89,830,783 | -$154,491,343 | -$64,660,560 | BLFS, SRPT, RLAY, EQRX, ALNY | 13F-HR | 14 Aug 2023, 15:12 |
| Q1 2023 | 40 | $1,210,552,890 | +$158,234,587 | -$195,034,774 | -$36,800,187 | BLFS, SRPT, RLAY, EQRX, ILMN | 13F-HR | 15 May 2023, 15:01 |
| Q4 2022 | 44 | $1,280,740,972 | +$199,899,547 | -$153,576,418 | +$46,323,129 | SRPT, BLFS, EQRX, ALNY, ILMN | 13F-HR | 14 Feb 2023, 14:01 |
| Q3 2022 | 36 | $1,515,354,000 | +$276,987,362 | -$176,721,209 | +$100,266,153 | EQRX, BLFS, SRPT, ALNY, BPMC | 13F-HR | 14 Nov 2022, 16:18 |
| Q2 2022 | 40 | $1,182,711,000 | +$49,554,723 | -$497,600,756 | -$448,046,033 | EQRX, ALNY, BLFS, RLAY, MXCT | 13F-HR | 15 Aug 2022, 13:16 |
| Q1 2022 | 47 | $2,230,233,000 | +$29,285,705 | -$330,574,859 | -$301,289,154 | BLFS, ALNY, EQRX, FATE, RLAY | 13F-HR | 16 May 2022, 12:32 |
| Q4 2021 | 53 | $3,548,006,000 | +$441,446,406 | -$198,227,113 | +$243,219,293 | BLFS, EQRX, FATE, NVTAQ, ALNY | 13F-HR | 14 Feb 2022, 11:19 |
| Q3 2021 | 53 | $4,008,437,000 | +$851,565,141 | -$170,471,304 | +$681,093,837 | NVTAQ, BLFS, EXAS, PACB, FATE | 13F-HR | 15 Nov 2021, 15:15 |
| Q2 2021 | 54 | $3,939,403,000 | +$603,306,496 | -$90,274,891 | +$513,031,605 | NVTAQ, BLFS, FATE, EXAS, VERV | 13F-HR | 16 Aug 2021, 13:56 |
| Q1 2021 | 48 | $3,357,621,000 | +$337,658,672 | -$162,970,720 | +$174,687,952 | NVTAQ, EXAS, FATE, BLFS, PACB | 13F-HR | 17 May 2021, 14:48 |
| Q4 2020 | 50 | $3,356,597,000 | +$685,412,739 | -$169,032,057 | +$516,380,682 | NVTAQ, BLFS, FATE, EXAS, BPMC | 13F-HR | 16 Feb 2021, 13:36 |
| Q3 2020 | 45 | $2,233,335,000 | +$382,101,740 | -$48,542,990 | +$333,558,750 | NVTAQ, BLFS, RLAY, BPMC, FATE | 13F-HR | 16 Nov 2020, 14:34 |
| Q2 2020 | 42 | $1,689,747,000 | +$420,298,539 | -$104,632,065 | +$315,666,474 | NVTAQ, BPMC, FATE, SRPT, MYOK | 13F-HR | 14 Aug 2020, 16:39 |
| Q1 2020 | 38 | $942,016,000 | +$201,117,723 | -$75,746,779 | +$125,370,944 | BPMC, SRPT, ALNY, FATE, CDXS | 13F-HR | 15 May 2020, 14:02 |
| Q4 2019 | 31 | $1,074,421,000 | +$83,353,659 | -$188,780,493 | -$105,426,834 | SRPT, BLUE, CDXS, BPMC, MYOK | 13F-HR | 14 Feb 2020, 16:35 |
| Q3 2019 | 33 | $966,300,626 | +$117,854,502 | -$20,077,870 | +$97,776,632 | ONCE, NVTAQ, CDXS, BPMC, SRPT | Restatement | 03 Jan 2020, 09:58 |
| Q2 2019 | 31 | $1,068,381,974 | +$198,968,276 | -$29,120,795 | +$169,847,481 | ONCE, NVTAQ, BPMC, CDXS, SAGE | 13F-HR | 13 Aug 2019, 14:11 |
| Q1 2019 | 29 | $910,374,000 | +$121,604,114 | -$77,464,289 | +$44,139,825 | ONCE, BPMC, MYOK, SAGE, BLUE | 13F-HR | 15 May 2019, 15:08 |
| Q4 2018 | 31 | $584,510,000 | +$51,848,406 | -$66,721,040 | -$14,872,634 | LOXO, MYOK, BPMC, CDXS, ONCE | 13F-HR | 13 Feb 2019, 16:42 |
| Q3 2018 | 34 | $814,429,000 | +$181,889,212 | -$100,890,205 | +$80,999,007 | LOXO, BPMC, MYOK, AGIO, SAGE | 13F-HR | 14 Nov 2018, 10:33 |
| Q2 2018 | 32 | $708,660,000 | +$124,153,977 | -$33,955,456 | +$90,198,521 | FMI, LOXO, BPMC, SAGE, MYOK | Restatement | 20 Aug 2018, 16:16 |
| Q1 2018 | 30 | $565,044,000 | +$91,959,492 | -$6,395,000 | +$85,564,492 | LOXO, FMI, SAGE, BPMC, ONCE | 13F-HR | 15 May 2018, 12:01 |
| Q4 2017 | 26 | $409,206,000 | +$53,051,841 | -$24,498,766 | +$28,553,075 | SAGE, FMI, LOXO, BPMC, BLUE | 13F-HR | 14 Feb 2018, 08:00 |
| Q3 2017 | 26 | $354,153,000 | +$65,841,771 | -$18,468,539 | +$47,373,232 | LOXO, MYOK, ALNY, SGMO, BPMC | 13F-HR | 14 Nov 2017, 08:16 |
| Q2 2017 | 31 | $250,031,000 | +$68,413,832 | -$10,931,694 | +$57,482,138 | LOXO, SAGE, FMI, BPMC, EVH | 13F-HR | 14 Aug 2017, 10:05 |
| Q1 2017 | 29 | $169,512,000 | +$36,102,160 | -$33,303,289 | +$2,798,871 | SAGE, FMI, LOXO, AGIO, BPMC | 13F-HR | 15 May 2017, 14:36 |
| Q4 2016 | 25 | $121,078,000 | +$30,943,358 | -$20,700,564 | +$10,242,794 | SAGE, LOXO, AGIO, FMI, EVH | 13F-HR | 14 Feb 2017, 13:01 |
| Q3 2016 | 26 | $123,498,000 | +$27,924,888 | -$28,520,955 | -$596,067 | AGIO, SAGE, FMI, EVH, BPMC | 13F-HR | 14 Nov 2016, 13:20 |
| Q2 2016 | 24 | $95,695,000 | +$25,673,746 | -$18,551,542 | +$7,122,204 | ONCE, AGIO, FMI, GBT, LOXO | 13F-HR | 15 Aug 2016, 12:45 |
| Q1 2016 | 25 | $84,542,000 | +$26,303,087 | -$19,829,039 | +$6,474,048 | LOXO, EPZM, FMI, SAGE, AGIO | 13F-HR | 09 May 2016, 11:41 |
| Q4 2015 | 27 | $107,415,000 | $0 | $0 | $0 | BPMC, SAGE, LOXO, CTMX, ONCE | 13F-HR | 08 Feb 2016, 07:33 |